Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Markets & Finance

Conseco Seeks to Delay Debt

Hawaiian Air (HA) reportedly decided not to extend its April 1 deadline of merger with Aloha Airgroup, Inc.

J Jill Group (JILL) raised its Q1 EPS guidance to $0.16-$0.18 vs. the previous $0.08-$0.10 target, on $72M in sales.

DB Alex Brown downgraded Bristol-Myers (BMY) to buy from strong buy on valuation concerns.

Conseco (CNC) offered to exchange up to $2.54B of its outstanding senior notes for new notes in a move to extend the maturity date of its debt. Moody's and Fitch placed Conseco's debt under review for a possible downgrade.

UBS Warburg initiated coverage of Global Imaging (GISX) with buy.

A.C.L.N. Ltd. (ASW) was delayed after the SEC reportedly suspended trading on NYSE until April 1 due to concerns over the accuracy of public information about the company.

Safenet (SFNT) will hold a conference call to update 2002 guidance after Monday's close. Pacific Growth believes the news is positive.

Bear Stearns upgraded Cerner Corp. (CERN) to buy from attractive.

SG Cowen reportedly upgraded Affiliated Computer (ACS) to strong buy from buy.

Needham resumed coverage of Helix Technology (HELX) with strong buy.

CIBC World reiterates buy on CryoLife (CRY). On Friday the company responded to an announcement by the Center for Disease Control by saying there are no epidemic of infections from tissue processed from its tissue banks.

Arch Coal (ACI) reduced the rates of coal production by 7% in recent weeks, and cut the 2002 capital expenditures budget to an expected $150M. Arch Coal also sees a $0.05-$0.15 Q1 loss, with Q2 likely to be affected as well.

Earthlink (ELNK) has been moving aggressively into the broadband market, and a recent deal with AT&T Broadband holds the potential to dramatically expand Earthlink's reach, according to press reports.

Qwest Communications (Q) continues to expect to become cash flow positive in Q2 2002, and amended a $4B unsecured bank credit agreement.

Cingular Wireless selected Intrado (TRDO) for phase I and II wireless 9-1-1 services.

Mechanical Dynamics (MDII) agreed to be acquired by MSC Software (MNS) for $18.85 cash per share.

JP Morgan reportedly downgraded AT&T Wireless (AWE) to market perform from buy.

Legg Mason upgraded Tibco Software (TIBX) to strong buy from buy.

A jury finds that Waters Corp.'s (WAT) Quattro Ultima series of mass spectrometers infringe on a patent owned by MDS Inc., exclusively licensed to Applera Corp. and PKI. The jury determined the damages in the amount of $47.5 million.

Johnson & Johnson (JNJ) says results from three separate clinical studies document continued excellent performance of investigational Cypher Sirolimus-eluting Stent in patients with coronary artery disease.

Network Associates (NET) offered to acquire all outstanding publicly held shares of (MCAF) it does not already own. Terms: 0.675 Network share for each McAfee share. Network currently owns about 75% of McAfee.

Audiovox (VOXX) revised fiscal 2001 (Nov.) results to a $0.16 Q4 loss. The company recorded an additional net charge of $1.2M relating to its wireless inventory.

Boston Scientific (BSX) filed an application with the FDA for pre-market approval of its Express coronary stent system, its Express2 coronary stent system -- rapid exchange and over-the-wire versions.

Robertson Stephens raised estimates and reiterates buy on Micron Technology (MU).

Progenics Pharmaceutical (PGNX) says its novel investigational drug, PRO 542, produced a significant antiviral response in HIV-infected individuals who were no longer responding to currently available antiretroviral medications.

Abbott Labs (ABT) will acquire the cardiovascular stent business of Biocompatibles for $234.5M cash.

CTB International (CTBC) retained Bear Stearns to develop alternatives to enhance shareholder value.

Buckeye Technology (BKI) filed a $300 million shelf registration.

blog comments powered by Disqus